Fatigue & insomnia

Alzheimer’s disease (or fuzzy thinking)? —
References & further reading

References

¹ Tavee, J., & Sweeney, P. 07/15/2006. Alzheimer’s.   www.clevelandclinicmeded.com/diseasemanagement/   neurology/alzheimers/alzheimers.htm

² Zhang, H., et al. 2004. Huperzine A enhances the level of secretory amyloid precursor protein and protein kinase C-alpha in intracerebroventricular beta-amyloid-(1-40) infused rats and human embryonic kidney 293 Swedish mutant cells. Neurosci. Lett., 360 (1–2), 21–24.

  Bai, D., et al. 2000. Huperzine A, a potential therapeutic agent for treatment of Alzheimer’s disease. Curr. Med. Chem., 7 (3), 355–374. Review.

  Ved, H. et al. 1997. Huperzine A, a potential therapeutic agent for dementia, reduces neuronal cell death caused by glutamate. Neuroreport, 8 (4), 963–968.

  For more information or to join a study currently underway on huperzine A in Alzheimer’s disease, visit the National Institutes of Health Clinical Trials webpage.

Further reading

For more information on Alzheimer’s, visit the following websites:

• National Institute on Aging: www.nia.nih.gov/alzheimers
• Alzheimer’s Association: www.alz.org
• Cleveland Clinic:
  www.clevelandclinicmeded.com/diseasemanagement/
  neurology/alzheimers/alzheimers.htm

Return to:

Alzheimer’s disease

 

Original Publication Date: 10/10/2006
Last Modified: 02/16/2010
Principal Author: Marcella Sweet